Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Temasek Buys Shares of Gilead Sciences, China’s 21Vianet

Don't Miss Out —
Follow us on:

Feb. 14 (Bloomberg) -- Temasek Holdings Pte, Singapore’s state-owned investment firm, added shares of pharmaceutical maker Gilead Sciences Inc. and Chinese Web data company 21Vianet Group Inc. in the fourth quarter.

Temasek, directly or through its units, bought 5.65 million shares of Foster City, California-based Gilead valued at $424 million as of Dec. 31 and 6.67 million American depositary receipts of Beijing-based 21Vianet worth $157 million, according to a filing today with the U.S. Securities and Exchange Commission.

Temasek, wholly owned by Singapore’s Ministry of Finance, is the ninth-biggest state investment company, according to the Sovereign Wealth Fund Institute website. The world’s biggest is Norway’s Government Pension Fund Global, while Singapore’s state fund GIC Pte is the eighth-biggest, according to the institute estimates.

The share of assets denominated in U.S. dollars in Temasek’s portfolio declined to 6 percent as of March 31 from 7 percent in the previous year, according to the investment firm’s latest annual review published in July.

Money managers who oversee more than $100 million in equities must file a Form 13F with the SEC within 45 days of each quarter’s end to show their U.S.-listed stocks, options and convertible bonds. The filings don’t show non-U.S. securities or how much cash the firms hold.

To contact the reporters on this story: Klaus Wille in Singapore at kwille@bloomberg.net; Devin Banerjee in New York at dbanerjee2@bloomberg.net

To contact the editors responsible for this story: Andreea Papuc at apapuc1@bloomberg.net; Christian Baumgaertel at cbaumgaertel@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.